An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter

Journal of Sichuan University (Medical Science)

Volumn 39, Issue 5, 2008, Pages 701-705

  Wang, Yan Ping ^a   Tang, Xiao Jun ^a   Zhou, Qing Hua ^a   Che, Guo Wei ^a   Chen, Xiao He ^a   Zhu, Da Xing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

hTERT; Lung cancer; Suicide gene; Targeting expression

Indexed keywords

EID: 53349164750     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Djojosubroto MW, Choi YS, Lee HW, et al. Telomeres and telomerase in aging, regeneration and cancer. Mol Cells, 2003;15(2):164-175.
2. Dong CK, Masutomi K, Hahn WC. Telomerase: regulation, function and transformation. Crit Rev Oncol Hematol,2005;54 (2):85-93.
3. Chinese source
4. Chinese source
5. Springer CJ, Niculescu-Duvaz I. Prodrug-activating systems in suicide gene therapy. J Clin Investi,2000;105(9):1161-1167.
6. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res, 2000;60(15):3989-3999.
7. Chinese source
8. Pulkkanen KJ,Parkkinen JJ, Laukkanen JM, et al. HSV-TK gene therapy for human renal cell carcinoma in nude mice. Cancer Gene Ther,2001;8(7):529-536.
9. Trask TW, Trask RP, Aguilar-Cordova E, et al. Phase I study of adenoviral delivery of the HSV-TK gene and ganciciclovir administration in patients with current malignant brain tumors. Mol Ther,2000;1(2):195-203.
10. Robson T, Hirst DG. Transcriptional targeting in cancer gene therapy. J Biomed and Biotech,2003;2(2003):110-137.
11. Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res,1999;59(3):551-557.
12. Koga S, Hrohata S, Kondo Y, et al. A novel telomerasespecific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. Human Gene Therapy,2000;11(10):0397-1406.
13. Komata T, Koga S, Hirohata S, et al. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter. International Journal of Oncology,2001;19(5):1015-1020.
14. Lin T, Huang XF,Gu J, et al. Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells. Oncogene, 2000;21(52):8020-8028.